Jland Biotech adds new collagen

China’s Jland Biotech is adding Biollagen-Lipo, a liposome-encapsulated grade of collagen. This is of non-animal origin and as such has no virus risk, low immunogenicity, no allergenicity, no rejection risk and good biocompatibility

China’s Jland Biotech is adding Biollagen-Lipo, a liposome-encapsulated grade, to its existing range of collagens. This is of non-animal origin and as such has no virus risk, low immunogenicity, no allergenicity, no rejection risk and good biocompatibility, the company said.

“The use of liposome encapsulation technology developed by JLand to wrap Biollagen SSE collagen leads to superior performance and has the obvious advantages of faster transdermal adsorption, stronger stability, slower release and longer acting, lower effective dose and reduced systemic adsorption,” the company added.

Latest Issues

CITE JAPAN 2025

Pacifico Yokohama
14th - 16th May 2025

NYSCC Suppliers' Day 2025

Javits Center, New York
3rd - 4th June 2025